You have 9 free searches left this month | for more free features.

Anlotinib (1)

Aumolertinib (1)

EGFR Activating Mutation (1)

NSCLC (1)

TP53 (1)

Not yet recruiting (1)

phase 2 (1)

Tianjin Medical University Cancer Institute and Hospital (1)

aumolertinib,anlotinib (1)

drug (1)

Other (1)

Interventional (1)

aumolertinib,anlotinib

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Not yet recruiting

Mar 8, 2023